Featured Research

from universities, journals, and other organizations

Crucial clumping of diabetes-causing proteins identified

Date:
November 11, 2013
Source:
University of Wisconsin-Madison
Summary:
Subtle differences in the shape of proteins protect some and endanger others. All mammals make this same protein called amylin, and it only differs a little bit from species to species. In the mammals that get type 2 diabetes, the amylin proteins aggregate in the pancreas into plaque that kills the cells around them, thereby ceasing all insulin production.

People get type 2 diabetes. So do cats. But rats don't, and neither do dogs.

Subtle differences in the shape of proteins protect some and endanger others.

"All mammals make this same protein called amylin, and it only differs a little bit from species to species," says Martin Zanni, a University of Wisconsin-Madison chemistry professor. "The mammals that get type 2 diabetes, their amylin proteins aggregate in the pancreas into plaque that kills the cells around them. As a result, you can't make insulin."

Without insulin, hungry cells can't tap sugar in the bloodstream for energy, and high blood sugar levels cause type 2 diabetes and its complications -- stroke, nerve damage and kidney disease among them.

Animal species that don't get type 2 diabetes find a way to keep plaque from forming in their pancreas and disrupting insulin production. Describing how their amylin proteins differ may provide a target for new treatments for diabetes and other plaque-involved disease such as Alzheimer's and Parkinson's.

A study published today by Zanni and collaborators in the Proceedings of the National Academy of Sciences paints that target on small clumps of mis-folding proteins in the middle of the plaque formation process.

"For about 30 years, we thought this problem was solved, because a lot of experiments pointed to the middle part of amylin molecules as the cause," Zanni says.

Named for its amino acid structure, the FGAIL regions of amylin proteins were believed to lock together -- "like boards in a wood floor," Zanni says -- into rigid sheets. The sheets, called beta-sheets, break apart, forming the dangerous plaque.

But experiments published in 2007 showed that the FGAIL section of amylin is floppy and loose, like a loop of rope. "This result made no sense compared to the 30 years of prior studies," Zanni says. "Why should the small differences in the amylin protein of various mammals play such a deciding role if those differences are located in a flexible, floppy and forgiving region of the protein?"

Zanni and collaborators showed that the floppy FGAIL region can contribute to the formation of plaque, but first, the amylin proteins must clump together in an arrangement in which the FGAIL region is indeed a rigid beta-sheet.

"That 30-year-old hypothesis is partly correct: the FGAIL region does indeed form the beta-sheets, but only for a little while until those sheets are broken to make the flexible loop," Zanni says.

The intermediate clumping step is where animal species resistant to type 2 diabetes are making their move.

"Our results indicate that the proteins in rats, dogs and other animals do not stop the plaques themselves, but instead target this upstream step," Zanni says, "preventing the intermediate from forming and thereby the plaques as well."

Using a technique called two-dimensional infrared spectroscopy developed in Zanni's lab, the new study -- which included collaborators at the University of California, Irvine, University of Chicago, Argonne National Lab and State University of New York at Stony Brook -- provides the first picture containing specific details of what the intermediate clumps look like.

"Good drugs work by fitting into nooks and crannies," says Zanni, whose work is funded by the National Institutes of Health. "Thus, it is much easier to design a drug when the shape of the toxic protein is known, which is what our data is beginning to provide."


Story Source:

The above story is based on materials provided by University of Wisconsin-Madison. Note: Materials may be edited for content and length.


Journal Reference:

  1. L. E. Buchanan, E. B. Dunkelberger, H. Q. Tran, P.-N. Cheng, C.-C. Chiu, P. Cao, D. P. Raleigh, J. J. de Pablo, J. S. Nowick, M. T. Zanni. Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient -sheet. Proceedings of the National Academy of Sciences, 2013; DOI: 10.1073/pnas.1314481110

Cite This Page:

University of Wisconsin-Madison. "Crucial clumping of diabetes-causing proteins identified." ScienceDaily. ScienceDaily, 11 November 2013. <www.sciencedaily.com/releases/2013/11/131111185227.htm>.
University of Wisconsin-Madison. (2013, November 11). Crucial clumping of diabetes-causing proteins identified. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/11/131111185227.htm
University of Wisconsin-Madison. "Crucial clumping of diabetes-causing proteins identified." ScienceDaily. www.sciencedaily.com/releases/2013/11/131111185227.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com
CDC Head Concerned About a Post-Antibiotic Era

CDC Head Concerned About a Post-Antibiotic Era

AP (July 22, 2014) Sounding alarms about the growing threat of antibiotic resistance, CDC Director Tom Frieden warned Tuesday if the global community does not confront the problem soon, the world will be living in a devastating post-antibiotic era. (July 22) Video provided by AP
Powered by NewsLook.com
Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins